免疫诺姆 IMNM
$18.71 +$0.81 (+4.50%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $19.48 +4.12%
开盘$18.21
昨收$17.91
当日区间$17.32 – $18.96
成交量1.33M
市值$2.21B
市盈率（TTM）–
股息率–
IMNM 相关新闻
匹配 Immunome 或代码 IMNM 的头条新闻，按最新排序。
- Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)
- A. G. P. Initiates Immunome(IMNM.US) With Buy Rating, Announces Target Price $32
- H.C. Wainwright Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40
- Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)
- A Quick Look at Today's Ratings for Immunome(IMNM.US), With a Forecast Between $33 to $40
- Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)
- Truist Financial Maintains Immunome(IMNM.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Immunome (IMNM) and Incyte (INCY)
- J.P. Morgan Maintains Immunome(IMNM.US) With Buy Rating
- J.P. Morgan Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $39
- Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN), Immunome (IMNM) and Alcon (ALC)
- Craig-Hallum Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $36
- Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33
- Lake Street Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $30
- Truist Financial Initiates Immunome(IMNM.US) With Buy Rating, Announces Target Price $37
暂无评论——快来第一个聊聊 IMNM。
登录后参与讨论。